Literature DB >> 6467160

Elevation of serum lactic dehydrogenase levels as an early marker of occult malignant lymphoma.

Z Rotenberg, I Weinberger, Y Fuchs, A Erdberg, E Davidson, J Agmon.   

Abstract

Elevated serum lactic dehydrogenase (LDH) levels, 595 to 615 microns/ml (normal less than 225 microns/ml) with predominance of LDH isoenzymes 2 and 3 was the early and only sign of occult malignant lymphoma in three patients. In the first patient, overt lymphoma appeared clinically only 2 months after the finding of elevated serum LDH levels, whereas in the other two asymptomatic patients, pathologic LDH levels were the only clues to the need for further diagnostic investigation. It is concluded that LDH may have a diagnostic value in the preclinical stage of malignant lymphoma. Thus, a patient with no apparent cause for elevated serum LDH levels warrants a thorough work-up including abdominal CT scan and even explorative laparotomy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467160     DOI: 10.1002/1097-0142(19841001)54:7<1379::aid-cncr2820540725>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Diagnostic and prognostic value of serum lactate dehydrogenase (LDH) and LDH isoenzymes in canine lymphoma.

Authors:  R Zanatta; O Abate; A D'Angelo; B Miniscalco; A Mannelli
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells--an immunocytochemical study.

Authors:  L Pan; P C Beverley; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

3.  Lactic acidosis, non-Hodgkins lymphoma and the acquired immunodeficiency syndrome.

Authors:  C Bergin; R Pilkington; C McCreary; F Mulcahy; V Crowley
Journal:  Genitourin Med       Date:  1994-04

4.  Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases.

Authors:  Yuling Wu; Caixia Lu; Nana Pan; Meng Zhang; Yi An; Mengyuan Xu; Lijuan Zhang; Yachong Guo; Lijuan Tan
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.